Hyun Woo Kim Selected Research

4- methyl- 5- (2- (4- morpholinophenylamino)pyrimidin- 4- yl)thiazol- 2- amine

5/2019

An Anti-Cancer Drug Candidate CYC116 Suppresses Type I Hypersensitive Immune Responses through the Inhibition of Fyn Kinase in Mast Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyun Woo Kim Research Topics

Disease

13	Congenital Abnormalities (Deformity) 04/2019 - 10/2007
9	Infections 02/2020 - 06/2011
8	Neoplasms (Cancer) 01/2022 - 07/2006
7	Inflammation (Inflammations) 01/2022 - 06/2006
6	Pain (Aches) 01/2021 - 02/2005
5	Cerebral Palsy (Spastic Diplegia) 01/2020 - 08/2008
5	Hypersensitivity (Allergy) 05/2019 - 01/2016
4	Adenocarcinoma 09/2021 - 03/2012
4	Body Weight (Weight, Body) 05/2019 - 11/2008
4	Anaphylaxis (Anaphylactic Shock) 05/2019 - 09/2013
4	Urinary Retention 01/2015 - 10/2004
4	Prostatitis 10/2012 - 06/2011
3	Type 2 Diabetes Mellitus (MODY) 10/2021 - 06/2015
3	Stomach Neoplasms (Stomach Cancer) 02/2020 - 01/2014
3	Carcinoma (Carcinomatosis) 10/2018 - 07/2006
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2017 - 06/2013
2	Carcinogenesis 01/2022 - 01/2016
2	Insulin Resistance 09/2021 - 06/2015
2	Human Influenza (Influenza) 07/2020 - 03/2019
2	Hip Dislocation 01/2020 - 11/2008
2	Weight Gain 05/2019 - 01/2016
2	Leukemia 03/2019 - 08/2006
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 04/2016
2	Food Hypersensitivity (Food Allergy) 05/2018 - 01/2016
2	Bacterial Infections (Bacterial Infection) 01/2018 - 02/2012
2	Overactive Urinary Bladder (Overactive Bladder) 09/2017 - 10/2004
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016 - 11/2013
2	Kyphosis 03/2016 - 10/2011
2	Gastritis 04/2014 - 01/2014
2	Persistent Infection 01/2013 - 08/2012
2	Foot Deformities (Foot Deformity) 03/2010 - 05/2006
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2009 - 04/2006
2	Lung Neoplasms (Lung Cancer) 04/2006 - 11/2004
1	Hyperglycemia 10/2021
1	Burns 01/2021
1	COVID-19 01/2021
1	Melena 12/2020
1	Hypertension (High Blood Pressure) 11/2020
1	Muscle Spasticity (Spastic) 01/2020

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2006
5	Bee Venoms (Bee Venom)IBA 01/2021 - 01/2005
4	AminesIBA 01/2022 - 01/2011
4	Pharmaceutical PreparationsIBA 10/2021 - 06/2009
4	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 06/2015
4	CytokinesIBA 03/2019 - 07/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 06/2011
3	CarcinogensIBA 01/2022 - 01/2014
3	EnzymesIBA 01/2022 - 01/2007
3	Immunoglobulin E (IgE)IBA 01/2018 - 01/2016
3	Type A Botulinum Toxins (Botox)FDA Link 12/2016 - 11/2008
2	AntioxidantsIBA 01/2022 - 05/2018
2	AntigensIBA 09/2021 - 09/2013
2	Triglycerides (Triacylglycerol)IBA 11/2020 - 11/2008
2	LipidsIBA 05/2019 - 11/2008
2	Interleukin-8 (Interleukin 8)IBA 03/2019 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 03/2019 - 01/2007
2	Interleukin-10 (Interleukin 10)IBA 05/2018 - 12/2017
2	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018 - 03/2015
2	Cholinergic Antagonists (Anticholinergics)IBA 09/2017 - 01/2015
2	Immunoglobulin G (IgG)IBA 11/2016 - 01/2015
2	Collagen Type II (Type II Collagen)IBA 01/2016 - 12/2009
2	piperineIBA 01/2016 - 01/2014
2	Biological ProductsIBA 01/2016 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 01/2007
2	Prostate-Specific Antigen (Semenogelase)IBA 06/2013 - 11/2008
2	Ciprofloxacin (Cipro)FDA LinkGeneric 06/2011 - 04/2011
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2011 - 02/2005
2	ChitosanIBA 02/2008 - 07/2006
2	AerosolsIBA 04/2006 - 11/2004
2	Estrogens (Estrogen)FDA Link 06/2003 - 03/2002
1	NitroreductasesIBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2022
1	GlucuronidaseIBA 01/2022
1	GlucosidasesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	azoreductaseIBA 01/2022
1	PrebioticsIBA 01/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022
1	schizandrin CIBA 10/2021
1	Gliclazide (Diamicron)IBA 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 09/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2021
1	Cytotoxins (Cytolysins)IBA 09/2021
1	Virulence Factors (Pathogenicity Factors)IBA 09/2021
1	VaccinesIBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	Substance PIBA 01/2021
1	C-Reactive ProteinIBA 11/2020
1	Neuraminidase (Sialidase)IBA 07/2020
1	Anti-Infective Agents (Microbicides)IBA 02/2020
1	caryophylleneIBA 02/2020

Therapy/Procedure

10	Osteotomy 01/2020 - 10/2007
5	Therapeutics 04/2015 - 10/2004
4	Aftercare (After-Treatment) 12/2020 - 10/2006
4	Solid-State Lasers 11/2016 - 06/2013
2	Ilizarov Technique 05/2016 - 03/2016
2	External Fixators 03/2016 - 02/2011
2	Arthrodesis 03/2010 - 08/2008